  See all
 |
Articles: Marketing/Media/ROI |
AstraZeneca announces TOPROL-XL (metoprolol succinate) is now available
AstraZeneca, 05/19/09
Free full text
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic, 05/15/09
Free full text
DeCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
deCODE genetics, 05/15/09
Free full text
Declining Market Demand Intensifies Competition
BioPharm, 05/14/09
Free full text
Social Marketing as a Strategy to Increase Immunization Rates
Archives of Pediatrics and Adolescent Medicine, 05/12/09 Amylin Drops 200 Sales Reps
PharmExec, 05/11/09 FDA Approves Pancreatic Enzyme Replacement Product for Marketing in United States
FDA Press Releases, 05/08/09
Free full text
Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
Amylin Pharmaceuticals, 05/05/09
Free full text
How to obtain a marketing authorization for an anticoagulant drug
Sang Thrombose Vaisseaux, 05/05/09 BioMimetic Therapeutics, Inc. Announces an $8 Million Private Placement; Company Intends to Commence Rights Offering
BioMimetic Therapeutics, 05/04/09 Nasdaq Stays Suspension of Trading in deCODE Stock
deCODE genetics, 04/30/09
Free full text
InVitria Reveals Technology to Optimize Hybridoma Production Performance
b3c newswire, 04/30/09 Medtronic Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent Thoracic Stent Graft
Medtronic, 04/28/09
Free full text
Teva Comments on Generic Evista Preliminary Injunction
Teva Pharmaceutical Industries, 04/24/09
Free full text
DeCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
deCODE genetics, 04/24/09
Free full text
US Pharma Market To Decline in 2009
PharmExec, 04/23/09 Start of large-scale production of Baycusan
BayNews International, 04/22/09
Free full text
Boehringer Ingelheim maintains its growth path in 2008, again growing faster than the pharmaceutical market - major investments once again in Research and Development - good outlook for further growth in 2009
Boehringer Ingelheim, 04/22/09
Free full text
Sepracor Announces Patent Interference Proceedings (and Schedule) Against Wyeth for Claims Related to O-desmethylvenlafaxine Succinate (Marketed as PRISTIQ(R))
Sepracor, 04/20/09 Retooling the Pharma Marketing Model
PharmExec, 04/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
235 Available Pages
|
|
